Start hereSafety guide
Urgent help — choose the right level of care
Use observable changes to choose routine, prompt, emergency, or crisis help in the United States without assigning a cause.
Answer
Choose care from what is happening now, not from a presumed fungal diagnosis. A stable concern can use routine assessment; worsening or a higher-risk context can need prompt care; observable immediate danger needs emergency help.
- A fungal or Candida label does not decide the care tier and cannot explain away new, spreading, persistent, or worsening findings.
- Routine, prompt, and emergency routes use different observable thresholds; a stable local concern is not presented as an emergency.
- Crisis support appears only for suicidal thoughts, inability to stay safe, or an acute emotional crisis, not for distress or a fungal concern alone.
- Confidence
- Strong confidence in the listed US care routes and observable triggers; they do not identify the condition causing a symptom.
- Why
- Current CDC clinical guidance and official US care, 911, and 988 services support these exact trigger and action boundaries, while canonical claims require clinical assessment rather than symptom-based diagnosis.
- Who this applies to
- Children and adults in the United States deciding whether a mouth, skin, nail, foot, known infection, or possible fungal concern needs routine, prompt, or emergency care.
- People in the United States who disclose suicidal thoughts, inability to stay safe, or an acute emotional crisis while seeking help for one of these concerns.
- Who needs a different route
- People seeking a diagnosis, probability estimate, or treatment recommendation from a symptom list; this page chooses a care route only.
- Product-specific allergic reactions, medication contraindications, and vaginal-symptom thresholds, which require the relevant product or condition safety record rather than a universal fungal rule.
Next steps
Safety and when to get care
This route is based on the observable trigger and does not identify a diagnosis.
Care tier: Routine care
- Observable trigger
- A person needs a nonemergency in-person assessment for a mouth, skin, nail, foot, or possible fungal concern and does not have a regular clinician or dentist.
- What to do
- Use the HRSA Find a Health Center service to locate a nearby federally funded health center, then ask the center whether it provides the needed primary, dental, or referral service.
- Exact population
- people in the United States who need nonemergency assessment and do not have an established care source
- Not covered here
- people with an immediate medical emergency
- people disclosing suicidal thoughts, inability to stay safe, or acute emotional crisis
- Source
Care tier: Routine care
- Observable trigger
- A person with diabetes notices foot tingling, burning, pain, loss of feeling, a color or temperature change, dry cracked skin, thick yellow toenails, athlete's-foot-like changes between the toes, an ingrown nail, blister, ulcer, or infected corn.
- What to do
- Visit the regular clinician or foot doctor for assessment rather than assuming the change is fungal or treating it without review.
- Exact population
- people in the United States with diabetes and at least one listed foot or nail change
- Not covered here
- people without diabetes
- people with signs of infection plus sepsis features or another immediate medical emergency
Care tier: Prompt care
- Observable trigger
- A person has thrush-like mouth changes or pain or difficulty swallowing and is living with HIV, receiving chemotherapy, taking immune-suppressing medicine, or otherwise has a weakened immune system.
- What to do
- Contact the treating healthcare team promptly for assessment and condition-specific testing; do not assume that mouth appearance alone identifies the cause or extent.
- Exact population
- children and adults in the United States with the observable symptom and at least one listed immune-risk context
- Not covered here
- people without a listed immune-risk context
- people who cannot breathe or have another immediate medical emergency
Care tier: Prompt care
- Observable trigger
- An unexplained rash is unusually severe or widespread, is spreading, or has not gone away after an antifungal treatment used as directed.
- What to do
- Contact a healthcare provider promptly for examination and testing, and report treatment used, travel, close skin contact, and any steroid-containing cream.
- Exact population
- children and adults in the United States with the listed observable rash course
- Not covered here
- a stable localized rash without a listed course change
- people with signs of sepsis or another immediate medical emergency
- Source
Care tier: Prompt care
- Observable trigger
- A known or suspected infection is not getting better or is getting worse, without the sepsis features or immediate danger listed in the emergency record.
- What to do
- Get medical care immediately and ask the healthcare professional whether emergency-department assessment is needed; do not use a fungal label to explain away worsening.
- Exact population
- children and adults in the United States with the observable worsening or nonresponse
- Not covered here
- people with clammy skin, confusion, extreme pain, fever or shivering, a high heart rate or weak pulse, shortness of breath, or another immediate medical emergency
- Source
Care tier: Emergency care
- Observable trigger
- A person with a known or suspected infection has clammy or sweaty skin, confusion or disorientation, extreme pain or discomfort, fever with shivering or feeling very cold, a high heart rate or weak pulse, or shortness of breath.
- What to do
- Treat this as a medical emergency: call 911 for immediate assistance or go to the nearest emergency department now, and say that an infection and possible sepsis are concerns.
- Exact population
- children and adults in the United States with a known or suspected infection and at least one listed observable sepsis feature
- Not covered here
- people with a stable local symptom and none of the listed emergency features
- Source
Care tier: Emergency care
- Observable trigger
- A person seeking help for an oral, skin, nail, foot, or serious fungal concern says they are thinking about suicide, cannot stay safe, or are in acute emotional crisis.
- What to do
- Call or text 988, or use 988 Lifeline chat, now for crisis support; call 911 for immediate danger or a simultaneous medical emergency.
- Exact population
- people in the United States who disclose the observable crisis trigger while seeking Pathway C help
- Not covered here
- people who are distressed by a symptom or diagnosis but do not disclose suicidal thoughts, inability to stay safe, or acute emotional crisis
In this pathway
- Parent problem or section
- Symptoms & conditions
- Current topic
- Urgent help — choose the right level of careCurrent
Sources behind these conclusions
Claim: Fever, chills, or other systemic illness features cannot by themselves identify invasive candidiasis or its site because manifestations are nonspecific and often occur in people already ill from other conditions; suspected invasive disease requires healthcare assessment and appropriate microbiological testing rather than symptom-based self-diagnosis or self-treatment.
Supported · Strong — CDC describes fever and chills as common but nonspecific, notes that affected patients are often already ill, and identifies blood culture as the primary diagnostic method. The global and IDSA guidelines treat invasive candidiasis as a clinician-managed disease defined by host context, site, cultures, species, and susceptibility rather than a consumer symptom cluster.
Sources for this claim
- Symptoms of Candidiasis (Regulator)
- Testing and Diagnosis for Candidiasis (Regulator)
- Clinical Overview of Invasive Candidiasis (Regulator)
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM (Guideline)
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (Guideline)
Claim: New, persistent, spreading, or worsening findings during or after antifungal treatment do not establish resistant or invasive fungal disease and should instead reopen the original diagnosis, body site, organism, host risk, exposure, treatment, adherence, and adverse-effect assessment.
Supported · Moderate — Current candidiasis authorities distinguish infection site, host context, species, susceptibility, initial response, refractory disease, and alternative diagnoses. CDC also notes that fungal conditions are frequently misdiagnosed and that delayed correct treatment can be consequential. Together these sources support reassessment rather than a single inference from nonresponse; they do not establish one universal interval, action, or care tier across conditions and treatments.
Sources for this claim
- Candidiasis Basics (Regulator)
- Testing and Diagnosis for Candidiasis (Regulator)
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM (Guideline)
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (Guideline)
Claim: Diabetes and weakened immunity are important modifiers for oral, skin, foot, and nail fungal problems, including persistence and complications, but neither modifier establishes that an observed lesion is fungal or supplies an individual likelihood ranking.
Supported · Strong — CDC identifies diabetes and immune impairment as risk modifiers for candidiasis and ringworm, and notes greater risk of bacterial complication with fungal nail infection in these groups. The same sources recommend examination or testing because observable findings have alternatives. Exact care thresholds and local actions belong to the US and Polish authority packs.
Sources for this claim
- Risk Factors for Candidiasis (Regulator)
- Clinical Overview of Ringworm (Regulator)
Start with the observable trigger
Use routine assessment for a stable mouth, skin, nail, foot, or possible fungal concern. A person with diabetes should show listed foot changes to their regular clinician or foot doctor rather than assuming the change is fungal. Contact the treating team promptly for thrush-like mouth changes or pain or difficulty swallowing with HIV, chemotherapy, immune-suppressing medicine, or another weakened-immune-system context. An unusually severe, widespread, spreading, or treatment-unresponsive rash needs prompt examination. A known or suspected infection that is not improving or is worsening needs immediate medical care. With a known or suspected infection, clammy skin, confusion, extreme pain, fever with shivering or feeling very cold, a high heart rate or weak pulse, or shortness of breath is an emergency trigger. Suicidal thoughts, inability to stay safe, or acute emotional crisis activate the separate crisis route; distress alone does not.
Match the action to routine, prompt, emergency, or crisis care
For a stable concern, contact the regular clinician, dentist, or foot doctor. If there is no established care source, use HRSA Find a Health Center and confirm that the site offers the needed service. For the listed higher-risk mouth or swallowing context or a severe, spreading, or nonresponsive rash, contact the treating team or another healthcare provider promptly. If a known or suspected infection is not improving or is worsening without emergency features, get medical care immediately and ask whether emergency-department assessment is needed. For the listed infection emergency features, call 911 or go to the nearest emergency department now. For suicidal thoughts, inability to stay safe, or acute emotional crisis, call or text 988 or use 988 Lifeline chat now; use 911 for immediate danger or a simultaneous medical emergency.
What these routes establish—and what they do not
These routes establish the appropriate service for an observable situation in the United States. They do not establish that Candida, another fungus, sepsis, or any other condition is the cause. Current authorities support assessment and testing when invasive disease is suspected, reassessment when findings persist or worsen, and separate review of diabetes or weakened-immunity context without turning those modifiers into a diagnosis. The canonical safety records above hold the exact trigger, tier, action, applicable population, source, check date, and expiry for every route on this draft.
Sources
View all 15 sources
- Candidiasis Basics
- Source type
- Regulator
- Published
- 2024-04-24
- Symptoms of Candidiasis
- Source type
- Regulator
- Published
- 2024-04-24
- Testing and Diagnosis for Candidiasis
- Source type
- Regulator
- Published
- 2024-04-24
- Risk Factors for Candidiasis
- Source type
- Regulator
- Published
- 2024-04-24
- Clinical Overview of Invasive Candidiasis
- Source type
- Regulator
- Published
- 2024-04-24
- Clinical Overview of Ringworm
- Source type
- Regulator
- Published
- 2024-07-15
- Treatment of Ringworm
- Source type
- Regulator
- Published
- 2026-02-09
- Diabetes Foot Problems: When to See Your Doctor
- Source type
- Regulator
- Published
- 2024-05-15
- About Sepsis
- Source type
- Regulator
- Published
- 2026-03-23
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
- Source type
- Guideline
- Published
- 2025-05-01
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- Source type
- Guideline
- Published
- 2016-02-15
- Thrush - children and adults
- Source type
- Other
- Published
- 2025-08-05
- Find a Health Center
- Source type
- Official care service
- Published
- 2026-07-10
- Calling 911
- Source type
- Official care service
- Published
- 2023-01-24
- 988 Suicide & Crisis Lifeline
- Source type
- Official care service
- Published
- 2022-07-16